Literature DB >> 28666709

Structural and functional brain signatures of C9orf72 in motor neuron disease.

Federica Agosta1, Pilar M Ferraro1, Nilo Riva2, Edoardo Gioele Spinelli3, Teuta Domi4, Paola Carrera5, Massimiliano Copetti6, Yuri Falzone7, Maurizio Ferrari8, Christian Lunetta9, Giancarlo Comi7, Andrea Falini10, Angelo Quattrini4, Massimo Filippi11.   

Abstract

This study investigated structural and functional magnetic resonance imaging abnormalities in hexanucleotide repeat expansion in chromosome 9 open reading frame 72 (C9orf72) motor neuron disease (MND) relative to disease severity-matched sporadic MND cases. We enrolled 19 C9orf72 and 67 disease severity-matched sporadic MND patients, and 22 controls. Sporadic cases were grouped in patients with: no cognitive/behavioral deficits (sporadic-motor); same patterns of cognitive/behavioral impairment as C9orf72 cases (sporadic-cognitive); shorter disease duration versus other sporadic groups (sporadic-early). C9orf72 patients showed cerebellar and thalamic atrophy versus all sporadic cases. All MND patients showed motor, frontal, and temporoparietal cortical thinning and motor and extramotor white matter damage versus controls, independent of genotype and presence of cognitive impairment. Compared with sporadic-early, C9orf72 patients revealed an occipital cortical thinning. C9orf72 patients had enhanced visual network functional connectivity versus sporadic-motor and sporadic-early cases. Structural cerebellar and thalamic damage and posterior cortical alterations are the brain magnetic resonance imaging signatures of C9orf72 MND. Frontotemporal cortical and widespread white matter involvement are likely to be an effect of the disease evolution rather than a C9orf72 marker.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; C9orf72; Cognitive deficits; Cortical thickness; Functional connectivity; White matter damage

Mesh:

Substances:

Year:  2017        PMID: 28666709     DOI: 10.1016/j.neurobiolaging.2017.05.024

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  26 in total

Review 1.  The imaging signature of C9orf72 hexanucleotide repeat expansions: implications for clinical trials and therapy development.

Authors:  Stacey Li Hi Shing; Mary Clare McKenna; We Fong Siah; Rangariroyashe H Chipika; Orla Hardiman; Peter Bede
Journal:  Brain Imaging Behav       Date:  2021-01-05       Impact factor: 3.978

Review 2.  Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Suvi Häkkinen; Stephanie A Chu; Suzee E Lee
Journal:  Neurobiol Dis       Date:  2020-09-02       Impact factor: 5.996

Review 3.  FTD spectrum: Neuroimaging across the FTD spectrum.

Authors:  Jennifer L Whitwell
Journal:  Prog Mol Biol Transl Sci       Date:  2019-06-18       Impact factor: 3.622

Review 4.  Cerebellar pathology in motor neuron disease: neuroplasticity and neurodegeneration.

Authors:  Rangariroyashe H Chipika; Grainne Mulkerrin; Pierre-François Pradat; Aizuri Murad; Fabrice Ango; Cédric Raoul; Peter Bede
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

5.  Temporal variant of frontotemporal dementia in C9orf72 repeat expansion carriers: two case studies.

Authors:  Francesca Caso; Federica Agosta; Giuseppe Magnani; Rosalinda Cardamone; Valentina Borghesani; Zachary Miller; Nilo Riva; Renaud La Joie; Giovanni Coppola; Lea T Grinberg; William W Seeley; Bruce L Miller; Maria Luisa Gorno-Tempini; Massimo Filippi
Journal:  Brain Imaging Behav       Date:  2020-04       Impact factor: 3.978

6.  Early Cognitive, Structural, and Microstructural Changes in Presymptomatic C9orf72 Carriers Younger Than 40 Years.

Authors:  Anne Bertrand; Junhao Wen; Daisy Rinaldi; Marion Houot; Sabrina Sayah; Agnès Camuzat; Clémence Fournier; Sabrina Fontanella; Alexandre Routier; Philippe Couratier; Florence Pasquier; Marie-Odile Habert; Didier Hannequin; Olivier Martinaud; Paola Caroppo; Richard Levy; Bruno Dubois; Alexis Brice; Stanley Durrleman; Olivier Colliot; Isabelle Le Ber
Journal:  JAMA Neurol       Date:  2018-02-01       Impact factor: 18.302

Review 7.  Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it?

Authors:  Fabiola De Marchi; Claudia Carrarini; Antonio De Martino; Luca Diamanti; Antonio Fasano; Antonino Lupica; Mirella Russo; Simone Salemme; Edoardo Gioele Spinelli; Alessandro Bombaci
Journal:  Neurol Sci       Date:  2021-03-27       Impact factor: 3.307

8.  Dipeptide repeat proteins activate a heat shock response found in C9ORF72-ALS/FTLD patients.

Authors:  Daniel A Mordes; Mercedes Prudencio; Lindsey D Goodman; Joseph R Klim; Rob Moccia; Francesco Limone; Olli Pietilainen; Kaitavjeet Chowdhary; Dennis W Dickson; Rosa Rademakers; Nancy M Bonini; Leonard Petrucelli; Kevin Eggan
Journal:  Acta Neuropathol Commun       Date:  2018-07-04       Impact factor: 7.801

9.  Cognitive Syndromes and C9orf72 Mutation Are Not Related to Cerebellar Degeneration in Amyotrophic Lateral Sclerosis.

Authors:  Monica Consonni; Eleonora Dalla Bella; Anna Nigri; Chiara Pinardi; Greta Demichelis; Luca Porcu; Cinzia Gellera; Viviana Pensato; Stefano F Cappa; Maria Grazia Bruzzone; Giuseppe Lauria; Stefania Ferraro
Journal:  Front Neurosci       Date:  2019-05-10       Impact factor: 4.677

10.  Burden of Rare Variants in ALS and Axonal Hereditary Neuropathy Genes Influence Survival in ALS: Insights from a Next Generation Sequencing Study of an Italian ALS Cohort.

Authors:  Stefania Scarlino; Teuta Domi; Laura Pozzi; Alessandro Romano; Giovanni Battista Pipitone; Yuri Matteo Falzone; Lorena Mosca; Silvana Penco; Christian Lunetta; Valeria Sansone; Lucio Tremolizzo; Raffaella Fazio; Federica Agosta; Massimo Filippi; Paola Carrera; Nilo Riva; Angelo Quattrini
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.